Gen 5 Fertility Center
Research
ONE OF THE MOST UNIQUE ASPECTS OF GEN 5 FERTILITY IS ITS EMPHASIS ON RESEARCH.
While most fertility centers focus only on what other researchers think are the “best” treatment strategies, we focus on improving the outcomes of all infertility patients, both those who receive care from us and those who must receive their care elsewhere.
One of the most important areas of research in reproductive medicine today is the use of PRP or EPF for Ovarian Rejuvenation. PRP is short for Platelet Rich Plasma Therapy and ERF is the abbreviation for Enriched Platelet Factors ( including EnPLAF). These two therapies are similar but also have significant differences. Please see our detailed webpage about Ovarian Rejuvenation for more information.
Over the past few years, the clinical and research staff at Gen 5 Fertility has published several scientific papers about PRP / EnPLAF and other topics. Below are PDF versions of some of these. Additional papers have been accepted or are being considered for publication at the present time.
Click to see one of the most important of our recent publications, one that provides the logical thinking and some of the prior research that explains how platelet derived growth factors may serve to rejuvenate the ovaries. It’s not an easy read. But, because it provides many of the details behind these procedures, it may be worth the effort.
Gen 5 Fertility Helps Create the Future of ReproductiveMedicine.
Sills ES, Wood SH (2022). Growth factors, gene activation and cell recruitment: From intraovarian condensed platelet cytokines to de novo oocyte development. J Clin Transl Res 2022; 8(1):49-53. DOI: http://dx.doi.org/10.18053/jctres.08.202201.008
Sills ES (2022). Ovarian recovery via autologous platelet-rich plasma: New benchmarks for condensed cytokine applications to reverse reproductive aging. Aging Medicine. 2022;00:1–5. DOI: http://dx.doi.org/10.1002/agm2.12196
Sills ES, Wood SH (2021). Appraisal of Experimental Methods to Manage Menopause and Infertility: Intraovarian Platelet-Rich Plasma vs. Condensed Platelet-Derived Cytokines. Medicina 58(1): 3 10.3390/medicina58010003
Sills ES, Rickers NS, Wood SH. (2020) Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: Fertility recovery and first unassisted conception with term delivery at age over 40. Int J Reprod BioMed 2020;18(12):1081-1086. https://knepublishing.com/index.php/ijrm/article/download/8030/13806
Sills ES, Wood SH. (2020). An experimental model for peri-conceptual COVID-19 pregnancy loss and proposed interventions to optimize outcomes. Int J Mol Cell Med 2020;9(3):1-8. http://dx.doi.org/10.22088/IJMCM.BUMS.9.3.180